期刊: BONE MARROW TRANSPLANTATION, 2022; 57 (3)
Hematopoietic stem cell transplantation (HSCT) from haploidentical donors is a viable option for patients lacking HLA-matched donors. Here we report t......
期刊: BONE MARROW TRANSPLANTATION, 2022; 57 (4)
Autologous hematopoietic cell transplantation (auto-HCT) may be performed in multiple myeloma (MM) patients relapsing after a previous auto-HCT. For t......
期刊: BONE MARROW TRANSPLANTATION, 2022; 57 (4)
The role of upfront autologous stem cell transplantation (ASCT) remains unclear in patients with primary central nervous system lymphoma (PCNSL) recei......